Navigation Links
Misonix Restructures and Expands Sales Organization in Europe
Date:9/2/2009

N) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and m
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
4. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
5. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
6. Misonix Announces New HIFU Distribution Agreement for Italy
7. Misonix Schedules Second Quarter Fiscal Year 2009 Financial Results Conference Call; February 9, 2009 at 4:30 P.M. Eastern
8. Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008
9. Misonix Announces New Distribution Agreement for Israel
10. Misonix Announces New Sales Agency Agreement for Eastern Europe
11. Misonix Announces New Distribution Agreement for Belgium and Luxembourg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Bayco’s ... with the introduction of the Nightstick XPP-5422GM , the world’s first Intrinsically ... at its base and one on its clip. The new Nightstick XPP-5422GM is ...
(Date:7/7/2015)... , ... July 07, 2015 ... ... leading provider of unified communication management solutions, has announced the release of ... , This service pack includes a number of enhancements to the already ...
(Date:7/7/2015)... DC (PRWEB) , ... July 07, 2015 , ... ... Officer and well-known patient advocate, will be recognized by the White House as ... Part of the newly-launched President’s Precision Medicine Initiative, the Champions of Change program ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... the pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such ... into any cell type in the human body. , iPSC-derived cardiomyocytes ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine ( ... Meeting, July 9-12 in Orlando, FL. As a leader in orthopaedic sports ...
Breaking Medicine News(10 mins):Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 3Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6
... , SAN DIEGO, Nov. 9 , , WHAT: All PETCO stores ... workshop facilitated by specially trained in-store nutrition, ... workshop, pet parents will learn about the nutritional needs of, ... to discuss the benefits of, good ...
... , This release is available in French . ... in twos: male and female. In human bodies trillions of cells ... are composed. Yet these don,t come in twos, they are ... backbone of life and illness scientists have long searched ...
... disease, often leading to disability or an increased risk ... Studies led by Deborah Young-Corbett, a faculty member in ... types of sanding tools are highly effective in reducing ... industry,s usage of the available technology remains very low. ...
... to read Charles Darwin,s "Origin of Species," whose publication celebrates its ... others who would like to know what the book is about, ... World-renowned evolutionary biologist David Reznick is the author of ... to the Origin of Species " (Princeton University Press, ...
... of seasonal flu could be severe in this group of ... Pregnant women who are depressed may suffer severe symptoms if ... State University researchers assessed depressive symptoms and took blood samples ... shot. Those with significant symptoms of depression had a stronger ...
... Industry leader ... 7 and Windows Server 2008 R2; aligns customer migration plans with solution readiness. , ... Scottsdale, AZ (PRWEB) Nov. 9, 2009 -- , , ... ready their IT environments for the migration to Windows 7 and Windows 2008 Server R2, ...
Cached Medicine News:Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:Book by UC Riverside biologist explains Darwin's 'Origin of Species' 2Health News:Depressed and Pregnant? Flu Shot May Be Needed 2Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 2Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 3Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 4
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... of a new generation of drugs within human ... established a sales company in the ... for Paccal Vet-CA1, its leading companion animal therapeutic. ...      (Photo: http://photos.prnewswire.com/prnh/20150703/228329 ) , ...
(Date:7/7/2015)... , July 7, 2015   Mallinckrodt plc ... results on Tuesday, August 4, 2015. A conference call for ...   The call can be accessed in ... http://www.mallinckrodt.com/investors . , By telephone: For both listen-only participants ... portion of the call, the telephone dial-in number in the ...
(Date:7/7/2015)... 7, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... non-binding Letter of Intent (LoI) for an investment and ... Sinopharm Capital Management Co. Ltd. and Hefei Life Science ... Hefei ) potentially valued at $50,000,000 plus ...
Breaking Medicine Technology:Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Mallinckrodt plc To Report Third Quarter Fiscal 2015 Results On August 4, 2015 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 3Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 4Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 5
... (NYSE: BSX ) is scheduled to present at ... Ray Elliott, President and Chief Executive Officer, will ... at approximately 9:30 a.m. PT.  Following the presentation, Jeff Capello, ... Elliott in a question and answer session. A ...
... Calif., Dec. 27, 2010 King Pharmaceuticals®, Inc. ... PTIE ) today announced that King has resubmitted ... U.S. Food and Drug Administration (FDA) in response to a ...  This is a Class 2 resubmission with a six month ...
Cached Medicine Technology:King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 2King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: